clinical trial · NCT04998981
A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C
Kowa Company, Ltd.·phase3·completed·n = 353
HyperlipidemiaK-877 0.1 mg tabletFenofibrate 200 mg capsulePlacebo tabletPlacebo capsuleK-877 0.1 mg tabletPlacebo tablet
brief summary
A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients with High TG and Low HDL-C
started
Sep 17, 2021
primary completion
Feb 2, 2023
completion
Feb 2, 2023
last updated
May 23, 2025
official title
A Phase 3, Multi-Center, Placebo- and Active-Controlled, Randomized, Double-Blind, 12-Week Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol